Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01245699 · ClinicalTrials.gov registry record · NA
MIHS Emergency Department CPR Quality Improvement Project
A NA study, sponsored by Valleywise Health.
- Completed
- Registry status
- NA
- Development phase
- 115
- Enrollment target
NCT01245699: Completed NA study, sponsored by Valleywise Health.
NCT01245699 is a NA study that has completed, run by Valleywise Health. The registered enrollment target is 115 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01245699, a NA study, has completed, sponsored by Valleywise Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 115 participants
- Enrollment target
Study Summary
The investigators will quantify the quality of chest compressions provided in the Emergency Department and determine whether the quality of chest compressions is related to patient outcome. The quality of chest compressions and patient outcomes will be assessed both before and after the introduction of audiovisual feedback in real time.
Primary Outcome
Measurement of chest compression depth
Interventions
- BEHAVIORAL scenario-based training, real-time audiovisual CPR feedback, and post-event debriefing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 115 participants |
| Start Date | 2010-06-09 |
| Est. Completion | 2016-03-09 |
| Phase | NA |
What the finished NCT01245699 record still lists
NCT01245699 is an interventional study that assigns participants to a tested intervention. The registered 115 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 1 intervention - of which scenario-based training, real-time audiovisual CPR feedback, and post-event debriefing is the first listed.
NCT01245699 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01245699 about?
NCT01245699 is a clinical study titled "MIHS Emergency Department CPR Quality Improvement Project". The investigators will quantify the quality of chest compressions provided in the Emergency Department and determine whether the quality of chest compressions is related to patient outcome. The quality of chest compressions and patient outcomes will be assessed both before and after the introduction...
What is the current status of trial NCT01245699?
This trial is currently completed. It is a NA study. The enrollment target is 115 participants. The study started on 2010-06-09. Estimated completion is 2016-03-09.
What interventions are being tested in trial NCT01245699?
The interventions under investigation include: scenario-based training, real-time audiovisual CPR feedback, and post-event debriefing (BEHAVIORAL).
Who is sponsoring clinical trial NCT01245699?
This trial is sponsored by Valleywise Health, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01245699's enrollment target sits among peer trials
115 810th of 2000 higher than 1,190 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02346929 · 115 participants · NA
Hematoma Block for Distal Radius Fracture
- NCT03394365 · 115 participants · Phase 3
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
- NCT03907475 · 115 participants · Phase 2
Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial
- NCT05086692 · 115 participants · Phase 1
A Beta-only IL-2 ImmunoTherapY Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI